Special Diabetes Program For Indians (Sdpi) Competitive Grant Program (93.442)

Program

93.442 Special Diabetes Program For Indians (Sdpi) Competitive Grant Program

Federal Agency

Agency: Department of Health and Human Services
Office: Indian Health Service

Authorization

Balanced Budget Act of 1997, Public Law 105-33; Consolidated Appropriations Act 2001, Public Law 106-554; Reauthorization of SDPI 2002, Public Law 107-360.

Program Number

93.442

Last Known Status

Active

Objectives

The Indian Health Service (IHS) announces a new initiative under the Special Diabetes Program for Indians (SDPI). This funding mechanism is a competitive grant program that will provide funding to selected SDPI grantees for a demonstration project to implement and evaluate defined activities in one of two areas (primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes).

Types of Assistance

PROJECT GRANTS

Uses and Use Restrictions

Funds (including direct costs and allowable indirect costs) may be used only for expenses clearly related and necessary to carry out approved activities that will support the implementation and evaluation of demonstration projects under this competitive grant program.

Eligibility Requirements

Applicant Eligibility

Applicants eligible to receive an award under this announcement are SDPI grant recipients. The applicant must be one of the following entities: IHS hospital or clinic, federally recognized Tribes, Title V Urban Indian Health Programs or consortia of any of the above. A SDPI grant recipient can apply only once as a single entity or as part of consortia. An application submitted by consortia of SDPI grant recipients must be submitted by one of the SDPI grant recipients sanctioned as the principal applicant. A letter of support must be included in the application from each SDPI grantee the principle applicant is representing. The letter must specifically state that the principal applicant is officially representing that SDPI grantee in this application. Applicants for consortia who do not submit these letters of support at the time of the application receipt date will not be reviewed and are ineligible for the award. Smaller applicants are encouraged to apply as part of consortia, especially their diabetes registry is less than 250. Applicants are strongly encouraged to establish eligibility of their proposed applications prior to submission. Inquires about eligibility should be addressed to Mary Tso, SDPI Grants Specialist, IHS National Diabetes Program at 505-248-4182; email to diabetesprogram@mail.ihs.gov. Applicants that are not SDPI grant recipients are not eligible. Non-profit tribal organizations or national/area health boards are not eligible, consistent with recent tribal consultation on this issue. Applications that do not meet these eligibility requirements will be returned to the applicant without further review.

Beneficiary Eligibility

American Indians and Alaska Natives will be the ultimate beneficiaries of the funded demonstration projects through either prevention or direct treatment services.

Credentials/Documentation

Costs will be determined in accordance with OMB Circular No. A-87, "Cost Principles for State, Local and Indian Tribal Governments" or OMB Circular No. A-122, "Cost Principles for Non-Profit Organizations.". OMB Circular No. A-87 applies to this program.

Application and Award Process

Preapplication Coordination

Preapplication coordination is required. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application Procedure

This program is excluded from coverage under OMB Circular No. A-102. OMB Circular No. A-110 applies to this program. Applications can be found in the grants.gov. Applications will also be available on request from the IHS National Diabetes Program at the following address: 5300 Homestead Road, NE, Albuquerque, NM 87110. Telephone: (505) 248-4182, fax 505-248-4188, email address: diabetesprogram@mail.ihs.gov. The application will be posted on the IHS National Diabetes Program web site at www.ihs.gov/medicalprograms/diabetes and on the HHS Grants web site at www.grants.gov. Applicants may submit one application for one or both demonstration projects. A separate application is required for each demonstration project. Applicants will be funded for only one project (primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes). Tribal Approval of Application/Letter of Support: It is the policy of the IHS that all projects involving AIAN tribes be approved by the Tribal governments with jurisdiction. Therefore, the following documentation is required as part of this application: 1) For federally recognized Indian tribe - a resolution of support from the Tribal government must be a part of the application. Applications that involve more than one Indian tribe must include resolutions of support from all participating tribes. 2) For an eligible consortium of tribes - a resolution of support from each tribe of the consortium must be included. 3) For Title V Urban Indian Health Programs - a letter of support from the program's board must be included. 4) For IHS hospitals or clinics - a letter of support from the Service Unit Director or Chief Executive Officer must be included. 5) For all applicants - letters of support from all partners and collaborating entities. The preferred method for receipt of applications is electronic submission through Grants.gov. However, should any technical problems arise regarding the submission, please contact Grants.gov Customer Support at 1-800-518-4726 or support@grants.gov. The Contact Center hours of operation are Monday-Friday from 7:00 a.m. to 9:00 p.m. (Eastern Standard Time). If you require additional assistance please contact Michelle G. Bulls, Grants Policy Officer; Telephone: (301) 443-6528 at least fifteen days prior to the application deadline. To submit an application electronically, please use the http://www.Grants.gov apply site. Download a copy of the application package, on the Grants.gov website, complete it offline and then upload and submit the application via the Grants.gov site. You may not e-mail an electronic copy of a grant application to us. Upon receipt, IHS will administratively review applications by completeness and responsiveness. Applications that are incomplete, non-responsive to this RFA, do not meet eligibility criteria or do not follow the guidelines of the SF 424 will be returned to the applicant without further consideration. Applications will be evaluated for technical merit by appropriate peer review groups convened by the IHS National Diabetes Program in accordance with established criteria.

Award Procedure

Applicants will only be eligible to receive one award for funding in one area (i.e. primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes. Priorities for funding will be based on the technical merit of the application, the assessed potential of the applicant and the likelihood of the applicant to successfully implement the defined interventions. Awards will be made only to organizations with financial management systems and management capabilities that are acceptable under PHS Policy. Awards will be administered under the PHS Grants Policy Statement. Awards will be subject to the availability of funds and grants will be administered in accordance with applicable Office of Management and Budget (OMB) Circulars, Department of Health and Human Services grant regulations at 45 CFR Parts 74 and 92, the Public Health Service Grants Policy Statement and other applicable IHS polices and procedures such as the regulations governing protection of human subjects at 45 CFR Part 46. Grants Management will not award a grant without an approved application in conformance with regulatory and policy requirements and which describes the purpose and scope of the project to be funded. When the application is approved for funding, the Grants Management Office will prepare a Notice of Grant Award with special terms and conditions binding upon the award and refer to all general terms applicable to the award.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time

From 60 to 90 days. The anticipated date for the announcement of selectees is 60 days after the application due date.

Appeals

Not Applicable.

Renewals

This funding will be awarded as a grant, renewable annually for up to 5 years. The IHS National Diabetes Program will determine if grants are renewable after 5 years depending on funding levels and congressional actions.

Assistance Considerations

Formula and Matching Requirements

Statutory formulas are not applicable to this program.

Matching requirements are not applicable to this program.

MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance

Assistance is availalble during the stated Project Periods. Method of awarding/releasing assistance: quarterly.

Post Assistance Requirements

Reports

Program reports are not applicable. Grantee will be required to submit, quarterly PMS 272 Federal Cash Transaction Reports to the Division Of Payment Management Branch. Depending on services provided, progress and financial reports will be required either quarterly or semi-annually with final performance and financial status reports due 90 after the end of the project period. A SF269 Financial Status Report will be due to the Division of Grants Management Operations 90 after the end of each budget period. IHS grants are monitored by the Division of Grants Management Operations for financial compliance and by the IHS Program Staff for programmatic compliance.

Audits

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments and Nonprofit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.

Records

Financial records of the grant must be retained for 3 years after submission of the final expenditure report. If questions remain, such as those resulting from an audit, pertinent records must be kept until the matter is resolved. The Secretary, the Inspector General of the Department of the Health and Human Services, and the Comptroller General of the United States or any of their authorized representatives shall have the right to access all records, report, books, document, papers or other records of the grantee, contractor, or subcontractor or of any entity pertinent to the DHHS grant in order to make audits, examinations, excerpts and transcripts.

Program Accomplishments

Not Applicable.

Financial Information

Account Identification

75-0390-0-1-551.

Obligations

(Salaries) FY 08 $23,300,000; FY 09 est $23,300,000; FY 10 est $23,300,000

Range and Average of Financial Assistance

No Data Available.

Regulations, Guidelines and Literature

Not Applicable.

Related Programs

Not Applicable.

Information Contacts

Regional or Local Office

See Regional Agency Offices. Program Contact: Dr. Kelly Acton, Director, Division of Diabetes Treatment and Prvention, 5300 Homestead Road, NE., Albuquerque, New Mexico 87110. Telephone: (505) 248-4182. Fax: (505) 248-4188. Grant Management contact: Ms. Kimberly Pendleton, Senior Grants Management Officer, Division of Grants Operations, Indian Health Service, 801 Thompson Avenue, TMP, Suite 360, Rockville, MD 20852. Telephone: (301) 443-5204. Fax: (301) 443- 9602.

Headquarters Office

IHS Grants Policy Staff 12300 Twinbrook Parkway, Suite 625, Rockville, Maryland 20852 Phone: 301-443-6290

Web Site Address

IHS National Diabetes Program: http://www.ihs.gov/medicalprograms/diabetes; http://www.grants.gov

Examples of Funded Projects

Not Applicable.

Criteria for Selecting Proposals

Not Applicable.